文献速递神经与头颈病理细胞病理与分子病理

新近描述的涎腺肿瘤:MASC、SPA与CAMSG综述

Newly described salivary gland tumors.
PubMed 文献 · Mod Pathol · 2017-01-01

本文综述三种新近被接受的涎腺肿瘤实体:乳腺类似分泌癌(MASC)、硬化性多囊性腺瘤(SPA)和舌及小涎腺筛状腺癌(CAMSG)。MASC为低度恶性癌,具有t(12;15)(p13;q25)易位致ETV6-NTRK3融合;SPA为罕见病变,现有克隆性、复发及异型增生证据提示真性肿瘤;CAMSG好发于舌,核透明显著,PRKD基因家族改变,原发时即常转移但行为惰性。

要点

  • MASC为低度恶性涎腺癌,特征性t(12;15)(p13;q25)易位致ETV6-NTRK3融合。
  • SPA罕见,组织学易误诊为低度恶性癌,克隆性及异型增生证据提示真性肿瘤。
  • CAMSG好发于舌,核透明显著,PRKD基因改变,原发时常转移但行为惰性。

核心结论

  • MASC、SPA和CAMSG是近二十年被描述并接受的新涎腺肿瘤实体。
  • 常规形态结合免疫组化仍是诊断最重要线索,分子病理提供新诊断工具及潜在预后指标。

研究设计与样本

  • 本文为综述,聚焦三种新近被文献接受为肿瘤实体的涎腺肿瘤:MASC、SPA和CAMSG。

主要发现

  • MASC为低度恶性涎腺癌,具有特征性t(12;15)(p13;q25)易位导致ETV6-NTRK3融合。
  • SPA为罕见病变,组织学常被误诊为低度恶性涎腺癌;先前认为是反应性纤维炎性过程,但近期克隆性证据、高达30%的复发及异型增生灶提示可能为真性肿瘤。
  • CAMSG不同于多形性低度腺癌(PLGA),好发于舌,核透明显著,有PRKD基因家族改变,原发肿瘤时即常转移。
  • CAMSG多数病例早期转移但行为惰性,在所有低度恶性涎腺肿瘤中独特。

关键数值与推荐

  • MASC特征性染色体易位为t(12;15)(p13;q25),导致ETV6-NTRK3融合。
  • SPA复发率高达30%,并有异型增生灶和克隆性证据。
  • CAMSG与PLGA鉴别点包括位置(常位于舌)、核透明显著、PRKD基因家族改变及原发时常转移。

临床怎么用

  • 诊断涎腺肿瘤时需注意形态学重叠,结合免疫组化和分子检测(如ETV6-NTRK3融合、PRKD基因改变)辅助鉴别。
  • 识别MASC、SPA和CAMSG这些新实体有助于避免误诊,并为预后判断提供分子指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This review concentrates on three salivary gland tumors that have been accepted in the recent literature as new neoplastic entities: mammary analog secretory carcinoma (MASC), sclerosing polycystic adenoma (SPA) and cribriform adenocarcinoma of tongue and other minor salivary glands (CAMSGs). MASC is a distinctive low-grade malignant salivary cancer that harbors a characteristic chromosomal translocation, t(12;15) (p13;q25) resulting in an ETV6-NTRK3 fusion. SPA is a rare lesion often mistaken histologically for low-grade salivary carcinoma. Previously thought to be a reactive fibroinflammatory process, but recent evidence of clonality, recurrences in up 30%, and dysplastic foci suggest it may be truly neoplastic. CAMSG is a distinct tumor entity that differs from polymorphous low-grade adenocarcinoma (PLGA) by location (ie, most often arising on the tongue), by prominent nuclear clearing, alterations of the PRKD gene family and clinical behavior with frequent metastases at the time of presentation of the primary tumor. Early metastatic disease seen in most cases of CAMSG associated with indolent behavior makes it a unique neoplasm among all low-grade salivary gland tumors. Salivary glands may give rise to a wide spectrum of different tumors. They are often diagnostically challenging as morphological features often overlap between different entities. Although conventional morphology in combination with immunohistochemical findings still provide the most important clues for diagnosis, recent advances in molecular pathology offer new diagnostic tools in investigating the differential diagnosis, as well as providing potentially valuable prognostic indicators. In the last two decades, several new salivary gland tumor entities have been described, namely MASC, SPA and CAMSGs.

来源:Mod Pathol,查看原文。版权归原作者所有。

引用

  1. Skalova A, Michal M, Simpson RH, et al. Newly described salivary gland tumors. Mod Pathol. 2017. PMID: 28060365. doi:10.1038/modpathol.2016.167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。